About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

LOG IN
LOG IN


H. Rept. 119-724 1 (2026-07-02)

handle is hein.congrecreports/crptxaikm0001 and id is 1 raw text is: AUTHENTICATED r U.S. GOVERNMENT INFORMATION 4 119TH CONGRESS REPORT 2d Session J HOUSE OF REPRESENTATIVES 119-724 STEM CELL THERAPEUTIC AND RESEARCH REAUTHORIZATION ACT OF 2025 JULY 2, 2026.-Committed to the Committee of the Whole House on the State of the Union and ordered to be printed Mr. GUTHRIE, from the Committee on Energy and Commerce, submitted the following REPORT [To accompany H.R. 5160] The Committee on Energy and Commerce, to whom was referred the bill (H.R. 5160) to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes, having considered the same, reports favorably thereon with an amendment and rec- ommends that the bill as amended do pass. CONTENTS Page Purpose and Sum m ary ........................................................................................... . 2 Background and Need for Legislation .................................................................... 3 C om m ittee A ction ................................................................................................... . 3 C om m ittee V otes ..................................................................................................... 4 Oversight Findings and Recommendations ........................................................... 6 New Budget Authority, Entitlement Authority, and Tax Expenditures ............. 6 Congressional Budget Office Estimate ................................................................... 6 Federal M andates Statem ent ................................................................................. 6 Statement of General Performance Goals and Objectives ................. 6 Duplication of Federal Program s ............................................................................ 6 Related Committee and Subcommittee Hearings ................................................. 6 Com m ittee Cost Estim ate ....................................................................................... 7 Earmark, Limited Tax Benefits, and Limited Tariff Benefits .............. 7 Advisory Com m ittee Statem ent .............................................................................. 7 Applicability to Legislative Branch ........................................................................ 7 Section-by-Section Analysis of the Legislation ...................................................... 7 Changes in Existing Law Made by the Bill, as Reported ................. 8 The amendment is as follows: Strike all after the enacting clause and insert the following: SECTION 1. SHORT TITLE. This Act may be cited as the Stem Cell Therapeutic and Research Reauthoriza- tion Act of 2025. 69-006